Pomerantz LLP is investigating claims on behalf of investors of Nano-X Imaging Ltd. following the company's announcement of a $33.4 million net loss in Q4 2025, largely due to a $17.5 million impairment charge related to restructuring its Korean chip facility. The investigation also concerns the resignation of CFO Ran Daniel, effective July 31, 2026. After the announcement, Nano-X's stock price dropped 24.39%, signaling investor concern. The law firm is examining whether Nano-X and its officers engaged in securities fraud or other unlawful practices, which could impact shareholders and the company's future operations.
The FDA granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) for children aged 8 to 17 recently diagnosed with stage 3 type 1 diabetes (T1D). Tzield slows the decline of the body's insulin production by targeting the autoimmune process c...
The FDA has granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) for children aged 8 to 17 recently diagnosed with stage 3 type 1 diabetes (T1D). This is the first disease-modifying therapy aimed at delaying the decline of insulin produc...
Heartland Express, Inc. announced a regular quarterly cash dividend of $0.02 per share, payable on July 6, 2026, to shareholders of record as of June 23, 2026. This marks the company's 92nd consecutive quarterly dividend, with a total payout of $564....
SpaceX is preparing for its IPO with a business model that blends rocket launches, satellite broadband via Starlink, and AI infrastructure, making it hard for investors to value. This mix means analysts must compare SpaceX to aerospace, telecom, and ...
Village Super Market, Inc. announced quarterly cash dividends of $0.25 per Class A share and $0.1625 per Class B share. These dividends will be paid on July 23, 2026, to shareholders recorded by July 2, 2026. The company operates 34 supermarkets unde...
